This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Tumor Metabolism: Mechanisms and Targets
joint with Adaptations to Hypoxia in Physiology and Disease
Organizer(s): Brendan D. Manning, Kathryn E. Wellen and Reuben J. Shaw
Date: March 05 - 09, 2017
Location: Whistler Conference Centre, Whistler, BC, Canada
Sponsored by Bayer HealthCare Pharmaceuticals, Cell Research, Merck & Co., Inc. and Takeda Pharmaceutical Company Limited
Summary of Meeting:
This conference is on the rapidly moving field of tumor metabolism and its implications in cancer development, progression and therapy. Experts from distinct fields of research will be brought together to present their latest discoveries on tumor metabolism, which is an inherently interdisciplinary field. Defining the diversity of metabolic strategies employed by cancer cells and how the genetic events underlying different types of cancer, as well as the tumor microenvironment, influence these metabolic properties is a major goal of this meeting. In addition, a combination of basic, translational and clinical studies will be presented, with the goal of identifying promising avenues in tumor metabolism that impact our understanding, diagnosis and treatment of cancer. In addition to a stellar line up of invited speakers, short talks and poster presentations will provide opportunities for researchers at all levels to discuss their most current work in this field. This meeting provides an excellent opportunity to share knowledge and methodology in tumor metabolism research in a collegial and social atmosphere.
Scholarship Deadline: November 8 2016
Discounted Abstract Deadline: November 8 2016
Abstract Deadline: December 8 2016
Discounted Registration Deadline: January 12 2017
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
Bayer HealthCare PharmaceuticalsCell ResearchMerck & Co., Inc.Takeda Pharmaceutical Company Limited
We gratefully acknowledge additional support for this conference from:
Bethyl Laboratories, Inc.Xcell Biosciences
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
BioMed Central Ltd - Cancer and Metabolism Journal
We gratefully acknowledge the generous grant for this conference provided by:

National Cancer Institute (NCI)
Grant No. 1R13CA213447-01
Funding for this conference was made possible (in part) by 1R13CA213447-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found